Literature DB >> 27062038

Is human herpesvirus 8 infection more common in men than in women? Systematic review and meta-analysis.

Lorin Begré1, Eliane Rohner1, Sam M Mbulaiteye2, Matthias Egger1,3, Julia Bohlius1.   

Abstract

All forms of Kaposi sarcoma (KS) are more common in men than in women. It is unknown if this is due to a higher prevalence of human herpesvirus 8 (HHV-8), the underlying cause of KS, in men compared to women. We did a systematic review and meta-analysis to examine the association between HHV-8 seropositivity and gender in the general population. Studies in selected populations like for example, blood donors, hospital patients and men who have sex with men were excluded. We searched Medline and Embase from January 1994 to February 2015. We included observational studies that recruited participants from the general population and reported HHV-8 seroprevalence for men and women or boys and girls. We used random-effects meta-analysis to pool odds ratios (OR) of the association between HHV-8 and gender. We used meta-regression to identify effect modifiers, including age, geographical region and type of HHV-8 antibody test. We included 22 studies, with 36,175 participants. Men from sub-Saharan Africa (SSA) [OR 1.21, 95% confidence interval (CI) 1.09-1.34], but not men from elsewhere (OR 0.94, 95% CI 0.83-1.06), were more likely to be HHV-8 seropositive than women (p value for interaction = 0.010). There was no difference in HHV-8 seroprevalence between boys and girls from SSA (OR 0.90, 95% CI 0.72-1.13). The type of HHV-8 assay did not affect the overall results. A higher HHV-8 seroprevalence in men than women in SSA may partially explain why men have a higher KS risk in this region.
© 2016 UICC.

Entities:  

Keywords:  Kaposi sarcoma; gender; human herpesvirus 8; meta-analysis; seroprevalence

Mesh:

Year:  2016        PMID: 27062038      PMCID: PMC5563519          DOI: 10.1002/ijc.30129

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  38 in total

1.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

Review 2.  The influence of sex and gender on the immune response.

Authors:  Sabine Oertelt-Prigione
Journal:  Autoimmun Rev       Date:  2011-12-03       Impact factor: 9.754

3.  Epidemiology of Kaposi's Sarcoma herpesvirus (HHV8) in Västerbotten County, Sweden.

Authors:  Rosamaria Tedeschi; Ettore Bidoli; Asa Agren; Göran Hallmans; Goran Wadell; Paolo De Paoli; Joakim Dillner
Journal:  J Med Virol       Date:  2006-03       Impact factor: 2.327

4.  Absence of sex-hormone receptors in Kaposi's sarcoma.

Authors:  J L Ziegler; E Katongole-Mbidde; H Wabinga; C M Dollbaum
Journal:  Lancet       Date:  1995-04-08       Impact factor: 79.321

5.  Prevalence and outcome of HIV-associated malignancies among children.

Authors:  Vincent J Tukei; Adeodata Kekitiinwa; R Palmer Beasley
Journal:  AIDS       Date:  2011-09-10       Impact factor: 4.177

6.  Gender differences in Kaposi's sarcoma-associated herpesvirus infection in a population with schistosomiasis in rural China.

Authors:  Bishi Fu; Rongge Yang; Fan Xia; Baolin Li; Xinxing Ouyang; Shou-Jiang Gao; Linding Wang
Journal:  Jpn J Infect Dis       Date:  2012-07       Impact factor: 1.362

7.  Increasing seroprevalence of human herpesvirus 8 (HHV-8) with age confirms HHV-8 endemicity in Amazon Amerindians from Brazil.

Authors:  A M G Cunha; A Caterino-de-Araujo; S C B Costa; E Santos-Fortuna; N C A Boa-Sorte; M S Gonçalves; F F Costa; B Galvão-Castro
Journal:  J Gen Virol       Date:  2005-09       Impact factor: 3.891

Review 8.  The effects of hormones on sex differences in infection: from genes to behavior.

Authors:  S L Klein
Journal:  Neurosci Biobehav Rev       Date:  2000-08       Impact factor: 8.989

9.  Risk factors for human herpesvirus 8 infection among adults in the United States and evidence for sexual transmission.

Authors:  Eric A Engels; Jonnae O Atkinson; Barry I Graubard; Geraldine M McQuillan; Christine Gamache; Georgina Mbisa; Silvia Cohn; Denise Whitby; James J Goedert
Journal:  J Infect Dis       Date:  2007-06-04       Impact factor: 5.226

10.  Kaposi sarcoma-associated herpesvirus (KSHV) seroprevalence in population-based samples of African children: evidence for at least 2 patterns of KSHV transmission.

Authors:  Lisa M Butler; Grant Dorsey; Wolfgang Hladik; Philip J Rosenthal; Christian Brander; Torsten B Neilands; Georgina Mbisa; Denise Whitby; Photini Kiepiela; Anisa Mosam; Similo Mzolo; Sheila C Dollard; Jeffrey N Martin
Journal:  J Infect Dis       Date:  2009-08-01       Impact factor: 5.226

View more
  11 in total

Review 1.  Cancer in adolescents and young adults living with HIV.

Authors:  Julia Bohlius; Caroline Foster; Gita Naidu; Mazvita Sengayi; Anna Turkova
Journal:  Curr Opin HIV AIDS       Date:  2018-05       Impact factor: 4.283

Review 2.  Malignancies in women with HIV infection.

Authors:  Nora T Oliver; Elizabeth Y Chiao
Journal:  Curr Opin HIV AIDS       Date:  2017-01       Impact factor: 4.283

3.  Molecular Epidemiology of Human Herpes Virus Type 8 Among Patients with Compromised Immune System in Ouagadougou, Burkina Faso.

Authors:  Nakougou Moϊ-Bohm Biatougou; Muriel S Ouedraogo; Serge Theophile Soubeiga; Theodora Mahoukede Zohoncon; Paul Ouedraogo; Dorcas Obiri-Yeboah; Aziz Sidi Aristide Tapsoba; Touwendpoulimdé Isabelle Kiendrebeogo; Tani Sagna; Pascal Niamba; Adama Traore; Jacques Simpore
Journal:  HIV AIDS (Auckl)       Date:  2022-07-08

4.  High Cancer Burden Among Antiretroviral Therapy Users in Malawi: A Record Linkage Study of Observational Human Immunodeficiency Virus Cohorts and Cancer Registry Data.

Authors:  Marie-Josèphe Horner; Steady Chasimpha; Adrian Spoerri; Jessie Edwards; Julia Bohlius; Hannock Tweya; Petros Tembo; Franklin Nkhambule; Eddie Moffo Phiri; William C Miller; Kennedy Malisita; Sam Phiri; Charles Dzamalala; Andrew F Olshan; Satish Gopal
Journal:  Clin Infect Dis       Date:  2019-08-16       Impact factor: 9.079

5.  Male hormones activate EphA2 to facilitate Kaposi's sarcoma-associated herpesvirus infection: Implications for gender disparity in Kaposi's sarcoma.

Authors:  Xing Wang; Zhe Zou; Zhaohui Deng; Deguang Liang; Xin Zhou; Rui Sun; Ke Lan
Journal:  PLoS Pathog       Date:  2017-09-28       Impact factor: 6.823

6.  Comparative transcriptome analysis of endemic and epidemic Kaposi's sarcoma (KS) lesions and the secondary role of HIV-1 in KS pathogenesis.

Authors:  Salum J Lidenge; Andrew V Kossenkov; For Yue Tso; Jayamanna Wickramasinghe; Sara R Privatt; Owen Ngalamika; John R Ngowi; Julius Mwaiselage; Paul M Lieberman; John T West; Charles Wood
Journal:  PLoS Pathog       Date:  2020-07-24       Impact factor: 6.823

7.  Kaposi's sarcoma-associated herpesvirus protein ORF75 among HIV-1 patients in Kenya.

Authors:  Rodgers N Demba; Sylviah M Aradi; Matilu Mwau; Walter O Mwanda
Journal:  Afr J Lab Med       Date:  2020-08-25

8.  Frequent HIV and Young Age Among Individuals With Diverse Cancers at a National Teaching Hospital in Malawi.

Authors:  Marie-Josèphe Horner; Ande Salima; Chrissie Chilima; Matthews Mukatipa; Wiza Kumwenda; Coxcilly Kampani; Fred Chimzimu; Bal Mukunda; Tamiwe Tomoka; Maurice Mulenga; Richard Nyasosela; Steady Chasimpha; Charles Dzamalala; Satish Gopal
Journal:  J Glob Oncol       Date:  2018-07

9.  MBL2 gene polymorphisms in HHV-8 infection in people living with HIV/AIDS.

Authors:  Viviane Martha Santos de Morais; Elker Lene Santos de Lima; Georgea Gertrudes de Oliveira Mendes Cahú; Thaisa Regina Rocha Lopes; Juliana Prado Gonçales; Maria Tereza Cartaxo Muniz; Maria Rosângela Cunha Duarte Coêlho
Journal:  Retrovirology       Date:  2018-11-27       Impact factor: 4.602

10.  Mannose-binding lectin concentrations in people living with HIV/AIDS infected by HHV-8.

Authors:  Viviane Martha Santos de Morais; Juliana Prado Gonçales; Georgea Gertrudes de Oliveira Mendes Cahú; Tania Regina Tozetto-Mendoza; Maria Rosângela Cunha Duarte Coêlho
Journal:  BMC Immunol       Date:  2019-01-03       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.